How Sex May Have Started it All

STRANDED SEX:© 2003 Elsevier ScienceIn this two-pot recombination scheme a ribozyme is incubated with an excess of RNA substrate A-B. The 3' portion of the substrate is covalently attached to the 3' end of the ribozyme in a "pick-up-the-tail" (PUTT) reaction. When the ribozyme is purified and incubated with an excess of substrate C-D, recombination (REC) of the substrates results in the product C-B. Exogenous GTP marginally improves recombination frequency which ranges from 5% to 45%. (From

Written byJack Lucentini
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

© 2003 Elsevier Science

In this two-pot recombination scheme a ribozyme is incubated with an excess of RNA substrate A-B. The 3' portion of the substrate is covalently attached to the 3' end of the ribozyme in a "pick-up-the-tail" (PUTT) reaction. When the ribozyme is purified and incubated with an excess of substrate C-D, recombination (REC) of the substrates results in the product C-B. Exogenous GTP marginally improves recombination frequency which ranges from 5% to 45%. (From Chem Biol, 10:1233–43, 2003)

Some researchers delving into the origins of life have sex on the brain. The prevailing thought in the field says that sex, typically defined as reproduction involving the fusion of genomes, emerged no more than 1.2 billion years ago. This is when eukaryotes, often haughtily considered the only organisms privileged enough to partake, evolved. But some are broadening the definition of the natural act and implicating it in life's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies